INHIBITION OF DNA REPLICATION AND REPAIR BY ANTHRALIN OR DANTHRON IN CULTURED HUMAN CELLSCLARK JM; HANAWALT PC.1982; J. INVEST. DERMATOL.; ISSN 0022-202X; USA; DA. 1982; VOL. 79; NO 1; PP. 18-22; BIBL. 20 REF.Article

Dithranol Therapy in Childhood Psoriasis: Unjustifiably on the Verge of Falling into OblivionDE JAGER, M. E. A; VAN DE KERKHOF, P. C. M; DE JONG, E. M. G. J et al.Dermatology (Basel). 2010, Vol 220, Num 4, pp 329-332, issn 1018-8665, 4 p.Article

THE INTERACTION OF ANTHRALIN, SALICYLIC ACID AND ZINC OXIDE IN PASTES = INTERACTION DE L'ANTHRALINE, DE L'ACIDE SALICYLIQUE ET DE L'OXYDE DE ZINC DANS LES POMMADESHULSEBOSCH HJ; PONEC WAELSCH M.1972; DERMATOLOGICA; SUISSE; DA. 1972; VOL. 144; NO 5; PP. 287-293; BIBL. 10REF.Serial Issue

Skin susceptibility to dithranol : contact allergy or irritation?LÖFFLER, H; EFFENDY, I; HAPPLE, R et al.EJD. European journal of dermatology. 1999, Vol 9, Num 1, pp 32-34, issn 1167-1122Article

Toxicologic study of anthralin in an aqueous cream formulationNEILL, S. M; BUGREIN, A; COULSON, I. H et al.Cutis (New York, NY). 1984, Vol 34, Num 5, pp 563-566, issn 0011-4162Article

THE INFLUENCE OF TREATMENT OF THE PARALESIONAL SKIN WITH DITHRANOL ON HEALING IN PSORIASIS = L'INFLUENCE DU TRAITEMENT DE LA PEAU PERILESIONNELLE PAR LE DITHRANOL SUR LA GUERISON DU PSORIASISSTANKLER L; DAVE VK.1975; BRIT. J. DERMATOL.; G.B.; DA. 1975; VOL. 92; NO 1; PP. 57-61; BIBL. 6 REF.Article

Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin)MUSTAKALLIO, K. K; BRANDT, H.Acta dermato-venereologica. 1984, Vol 64, Num 1, pp 63-66, issn 0001-5555Article

Untersuchungen zum Oxidationsverhalten von Dithranol = Etudes sur le comportement après oxydation du dithranol = Studies on the oxidation behaviour of dithranolSCHALTEGGER, A.Arzneimittel-Forschung. 1985, Vol 35, Num 4, pp 666-668, issn 0004-4172Article

ZUR ANTIPSORIATISCHENWIRKUNG VON DITHRANOL (ANTHRALIN). ERSTER TEIL = ACTION ANTIPSORIASIQUE DU DITHRANOL (ANTHRALINE). PREMIERE PARTIERAAB W.1975; HAUTARZT; DTSCH.; DA. 1975; VOL. 26; NO 9; PP. 452-455; ABS. ANGL.Article

SEPARATION, IDENTIFICATION, AND QUANTITATION OF ANTHRALIN AND ITS DECOMPOSITION PRODUCTSELSABBAGH HM; WHITWORTH CW; SCHRAMM LC et al.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 3; PP. 388-390; BIBL. 21 REF.Article

THE MANAGEMENT OF CHRONIC DISCOID PSORIASIS.1978; DRUG THERAPEUT. BULL.; G.B.; DA. 1978; VOL. 16; NO 7; PP. 25-27; BIBL. 15 REF.Article

DISPARITION DES LESIONS PSORIASIQUES SOUS ANTHRALINECHOWANIEC O.1976; PRZEGL. DERMATOL.; POLSKA; DA. 1976; VOL. 63; NO 5; PP. 665-671; ABS. RUSSE ANGL.; BIBL. 15 REF.Article

PSORIASIS-THERAPIE MIT CIGNOLIN CERCLE (DIHYDROXYANTHRANOL): DAS KOELNER CSV-THERAPIE-SCHEMA = TRAITEMENT DU PSORIASIS PAR LA CIGNOLINE CERCLE (DIHYDROXYANTHRANOL): SCHEMA THERAPEUTIQUE ASSOCIANT CIGNOLINE, ACIDE SALICYLIQUE ET VASELINE, UTILISE A COLOGNEORFANOS CE; STEIGLEDER GK.1976; Z. HAUTKRANKH.; DTSCH.; DA. 1976; VOL. 51; NO 12; PP. 473-480; BIBL. 24 REF.Article

SYSTEMIC USE OF A NEW RETINOID WITH AND WITHOUT LOCAL DITHRANOL TREATMENT IN GENERALIZED PSORIASIS.ORFANOS CE; RUNNE U.1976; BRIT. J. DERMATOL.; G.B.; DA. 1976; VOL. 95; NO 1; PP. 101-103; BIBL. 6 REF.Article

PSORIASIS: A REVIEW. IIBAKER H.1975; DERMATOLOGICA; SUISSE; DA. 1975; VOL. 150; NO 3; PP. 136-153; BIBL. 2 P.Article

Anthralin stability in various vehiclesGREEN, P. G; KENNEDY, C. T. C; FORBES, D. R et al.Journal of the American Academy of Dermatology. 1987, Vol 16, Num 5, pp 984-988, issn 0190-9622, 1Article

Anthralin stain removalWANG, J. C. T; KRAZMIEN, R. J; DAHLHEIM, C. E et al.Journal of the American Academy of Dermatology. 1986, Vol 15, Num 5, pp 951-955, issn 0190-9622, part 1Article

Short-duration dithranol therapy for psoriasisHINDRYCKX, P; DE BERSAQUES, J.Dermatologica. 1983, Vol 167, Num 6, pp 304-306, issn 0011-9075Article

Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet b for psoriasis: a randomized, within-patient controlled trialMCBRIDE, S. R; WALKER, P; REYNOLDS, N. J et al.British journal of dermatology (1951). 2003, Vol 149, Num 6, pp 1259-1265, issn 0007-0963, 7 p.Article

Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasisHOPMANN, U. B; EGGERT, A. A. O; BRÖCKER, E-B et al.British journal of dermatology (1951). 2003, Vol 148, Num 4, pp 779-783, issn 0007-0963, 5 p.Article

Dithranol abolishes UCH-L1 immunoreactivity in the nerve fibers of the rat orofacial skinOROJAN, Ivan; SZIGETI, Csaba; VARSZEGI, Sziluia et al.Brain research. 2006, Vol 1121, pp 216-220, issn 0006-8993, 5 p.Article

The effect of treatment on quality of life in psoriasis patientsPRINS, Mandy; KRABBE, Paul F. M; SWINKELS, Quintus O. J et al.Acta dermato-venereologica. 2005, Vol 85, Num 4, pp 304-310, issn 0001-5555, 7 p.Article

Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasisSWINKELS, O. Q. J; PRINS, M; VEENHUIS, R. T et al.EJD. European journal of dermatology. 2004, Vol 14, Num 3, pp 159-165, issn 1167-1122, 7 p.Article

Lycopene from Tomatoes: Vesicular Nanocarrier Formulations for Dermal DeliveryASCENSO, Andreia; PINHO, Sónia; ELEUTERIO, Carla et al.Journal of agricultural and food chemistry (Print). 2013, Vol 61, Num 30, pp 7284-7293, issn 0021-8561, 10 p.Article

Current status and recent developments in anthracenone antipsoriaticsMÜLLER, Klaus.Current pharmaceutical design. 2000, Vol 6, Num 9, pp 901-918, issn 1381-6128Article